Haemonetics Long-Term Investments 2010-2025 | HAE

Haemonetics long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Haemonetics Annual Long-Term Investments
(Millions of US $)
2025 $0
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Haemonetics Quarterly Long-Term Investments
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.442B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.094B 27.91
Boston Scientific (BSX) United States $148.004B 37.05
Stryker (SYK) United States $145.912B 30.51
EssilorLuxottica (ESLOY) France $130.051B 0.00
Medtronic (MDT) Ireland $112.158B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.407B 0.00
Haleon (HLN) United Kingdom $48.971B 27.90
ResMed (RMD) United States $36.801B 27.64
Agilent Technologies (A) United States $33.162B 21.62
GE HealthCare Technologies (GEHC) United States $32.817B 15.58
Terumo (TRUMY) Japan $26.665B 34.63
Koninklijke Philips (PHG) Netherlands $22.070B 15.86
Insulet (PODD) United States $21.511B 84.44
Zimmer Biomet Holdings (ZBH) United States $18.366B 11.80
Baxter (BAX) United States $15.831B 11.82
Smith & Nephew SNATS (SNN) United Kingdom $13.086B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.138B 21.36
Lantheus Holdings (LNTH) United States $5.758B 14.52
Prestige Consumer Healthcare (PBH) United States $4.234B 18.91
Perrigo (PRGO) Ireland $3.598B 9.12
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.353B 24.73
Envista Holdings (NVST) United States $3.224B 26.79
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.043B 14.05
LeMaitre Vascular (LMAT) United States $1.883B 42.08
AtriCure (ATRC) United States $1.692B 0.00
Acuren (TIC) United States $1.348B 0.00
Neogen (NEOG) United States $1.198B 15.33
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.132B 0.00
Kestra Medical Technologies (KMTS) United States $1.087B 0.00
Green Thumb Industries (GTBIF) United States $1.082B 24.33
Phibro Animal Health (PAHC) United States $0.982B 12.55
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.644B 0.00
Evolus (EOLS) United States $0.622B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Capricor Therapeutics (CAPR) United States $0.611B 0.00
Curaleaf Holdings (CURLF) Canada $0.581B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.413B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.91
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.327B 58.20
Canopy Growth (CGC) Canada $0.298B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.281B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Cresco Labs (CRLBF) United States $0.263B 0.00
ZimVie (ZIMV) United States $0.261B 11.89
Sanara MedTech (SMTI) United States $0.258B 0.00
Sanuwave Health (SNWV) United States $0.258B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.215B 6.05
OraSure Technologies (OSUR) United States $0.214B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 55.05
Quanterix (QTRX) United States $0.196B 0.00
High Tide (HITI) Canada $0.191B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.08
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.184B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.133B 16.40
Vireo Growth (VREOF) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Veru (VERU) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.50
TerrAscend (TSNDF) Canada $0.083B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.040B 54.43
United-Guardian (UG) United States $0.038B 13.25
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00